Challenges and Strategies to Combat Resistance Mechanisms in Thyroid Cancer Therapeutics.

Gild, Matti L; Bullock, Martyn; Tsang, Venessa; Clifton-Bligh, Roderick J; Robinson, Bruce G; Wirth, Lori J

Gild, Matti L; Bullock, Martyn; Tsang, Venessa; Clifton-Bligh, Roderick J; Robinson, Bruce G; Wirth, Lori J.

Afiliación

Gild ML; Cancer Genetics Laboratory, Kolling Institute, Sydney, Australia.
Bullock M; Department of Endocrinology and Diabetes, Royal North Shore Hospital, Sydney, Australia.
Tsang V; Northern Clinical School, Faculty of Health and Medicine, University of Sydney, Sydney, Australia.
Clifton-Bligh RJ; Cancer Genetics Laboratory, Kolling Institute, Sydney, Australia.
Robinson BG; Northern Clinical School, Faculty of Health and Medicine, University of Sydney, Sydney, Australia.
Wirth LJ; Department of Endocrinology and Diabetes, Royal North Shore Hospital, Sydney, Australia.

Thyroid ; 33(6): 682-690, 2023 06.

Article en En | MEDLINE | ID: mdl-36924302

Asunto(s)

Neoplasias Pulmonares; Neoplasias de la Tiroides; Humanos; Proteínas Tirosina Quinasas/genética; Neoplasias Pulmonares/tratamiento farmacológico; Proteínas Proto-Oncogénicas/genética; Proteínas Tirosina Quinasas Receptoras/genética; Neoplasias de la Tiroides/genética; Mutación; Inhibidores de Proteínas Quinasas/uso terapéutico

Palabras clave

resistance mechanisms; thyroid cancer; tyrosine kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Thyroid Asunto de la revista: ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google